Last month, the Food and Drug Administration (FDA) approved Voquenza Dual (vonoprazan fumarate + amoxicillin) and Triple Paks (vonoprazan fumarate + amoxicillin + clarithromycin) for the treatment of ...

The American Journal of Managed Care® (AJMC®): What treatment options or regimens for Helicobacter pylori exist that are not reflected in the 2017 American College of Gastroenterology (ACG) guidelines ...

Patients with Helicobacter pylori infection were randomly assigned to receive triple therapy for the eradication of bacterium for one week, or no treatment. As controls, 25 patients with chronic ...

European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission We conducted a retrospective cohort ...

The American Journal of Managed Care® (AJMC®): What has led to the recent increase in attention given to Helicobacter pylori treatments? Our group, as well as other groups in the United States, [has] ...

Helicobacter pylori (H. pylori) is a type of bacteria that infects the stomach and small bowel. It is often symptomless, but it can increase the risk of ulcers, gastritis, and cancer, all of which can ...

The factors that influence the success of H. pylori treatment include the appropriate drugs, doses, dosing interval, and treatment duration in your local area of practice. A clinician knowledgeable ...

Daniela B. Engler, Sebastian Reuter, Yolanda van Wijck, Sabine Urban, Andreas Kyburz, Joachim Maxeiner, Helen Martin, Nir Yogev, Ari Waisman, Markus Gerhard, Timothy L. Cover, Christian Taube, Anne ...

(RTTNews) - RedHill Biopharma Ltd. (RDHL) Monday said the U.S. Patent and Trademark Office (USPTO) has granted new patent for Talicia indicated for the treatment of Helicobacter pylori (H. pylori) ...

| DelveInsight The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based ...